Search clinical trials for: Varenicline Tartrate or bupropion

Total 83 results

University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKING) (GENTSMOKING)

Smoking Cessation | Genetic Predisposition

Brazil
Vastra Gotaland Region

Completed

Varenicline and Bupropion for Alcohol Use Disorder

Alcohol Dependence | Alcoholism | Alcohol Use Disorder

Sweden
Korea University Anam Hospital

Completed

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1502

Healthy

Korea, Republic of
Pfizer

Completed

A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.

Smoking Cessation

United States
Pfizer

Completed

Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers

Smoking Cessation

United States
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease

Dry Eye Disease

China
Yale University

Completed

Varenicline for Treatment of E-cigarette Dependence

Smoking Cessation

United States
Pfizer

Completed

Phase 1 Clinical Trial of Varenicline in Chinese Healthy Smoking Volunteers

Smoking

China
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease

Dry Eye Disease

China
Pfizer

Completed

An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking

Smoking Cessation

Thailand, Singapore, China
Pfizer

Completed

A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction

Smoking Cessation

United States, Taiwan, Australia, Germany, Egypt, United Kingdom, Canada, Czech Republic, Mexico, Japan
University of Kentucky
Kentucky Lung Cancer Research Program

Completed

Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies

Head and Neck Cancer | Lung Cancer

United States
Pfizer

Completed

An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation

Smoking Cessation | Pharmacokinetics | Bioavailability

United States
Pfizer

Completed

Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).

Smoking Cessation

United States, France, Italy, Spain
University of Kansas Medical Center

Recruiting

Switching to E-cigarettes in African-American Smokers

Smoking Reduction

United States
The Queen Elizabeth Hospital

Completed

Smoking Termination Opportunity for inPatients (STOP)

Tobacco Use Disorder

Australia
Duke University
Philip Morris USA, Inc.

Terminated

Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants (LiveForLife2)

Nicotine Dependence | Cigarette Smoking

United States
Pfizer

Completed

Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use

Tobacco Use Cessation

Norway, Sweden
Pfizer

Completed

Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking

Smoking Cessation

Colombia, Mexico, Egypt, Jordan, Brazil, Costa Rica, Lebanon, Saudi Arabia, South Africa, United Arab Emirates, Venezuela
Mayo Clinic

Completed

Varenicline Treatment for Active Alcoholic Smokers

Smoking | Alcohol Dependence | Tobacco Dependence

United States
Pfizer
GlaxoSmithKline

Completed

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders (EAGLES)

Smoking Cessation

United States, Spain, Germany, Canada, South Africa, Finland, Denmark, Australia, Brazil, Bulgaria, Chile, Mexico, New Zealand, Russian Federation, Slovakia, Argentina
Pfizer

Completed

Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (CATS)

Smoking Cessation

United States, Spain, Germany, Canada, South Africa, Finland, Denmark, Australia, Argentina, Brazil, Bulgaria, Chile, Mexico, New Zealand, Russian Federation, Slovakia
Mayo Clinic

Completed

Varenicline For Smokers In Recovery From Alcohol Dependence

Tobacco Abstinence

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior

Smoking Lapse Behavior

United States
Yale University
National Cancer Institute (NCI)

Active, not recruiting

A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV (SMARTTT)

Tobacco Use Cessation

United States
Mayo Clinic

Completed

Chantix & Bupropion for Smoking Cessation (ChanBan)

Smoking | Tobacco Use Disorder

United States
Centre for Addiction and Mental Health
Ontario Ministry of Health and Long Term Care

Completed

Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts

Smoking | Smoking Cessation | Tobacco Use Disorder

Canada
Fundación Pública Andaluza para la gestión de la...
Andaluz Health Service; European Commission

Completed

So-Lo-Mo Intervention Applied to the Smoking Cessation Process (So-Lo-Mo)

Smoking Cessation | Health Behavior | Lifestyle-related Condition
University of Oulu
Lapland Central Hospital Rovaniemi Finland

Completed

Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy Smokers (EFFECT)

Smoking Cessation | Electronic Cigarette

Finland
University of Kansas Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Individualizing Pharmacotherapy for African American Smokers

Smoking Cessation

United States
UConn Health
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Exercise or Relaxation for Smoking Cessation

Smoking Cessation | Nicotine Dependence

United States
University of Chicago
Pfizer

Completed

Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation

Alcohol Drinking | Smoking Cessation

United States
Philip Diaz
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Smoking Cessation Using Motivational Therapy and Varenicline

HIV Infections | Smoking

United States
Duke University
Philip Morris USA, Inc.

Completed

Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype (ConNic3)

Smoking Cessation

United States
University of Pittsburgh
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Connect to Quit for Smoking (CTQ)

Smoking | Smoking Cessation

United States
Duke University
National Institute on Drug Abuse (NIDA)

Completed

Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation (ConNicBrain)

Nicotine Dependence

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial

Cigarette Smoking-Related Carcinoma

United States
Thomas Jefferson University

Active, not recruiting

Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

Head and Neck Squamous Cell Carcinoma | Lung Non-Small Cell Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI); University of Minnesota

Completed

Varenicline and Bupropion for Smoking Cessation (CHANBAN)

Smoking

United States
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Smoking Interventions for Hospital Patients (Helping HAND)

Cigarette Smoking

United States
Chinese PLA General Hospital

Unknown

Study on the Model of Smoking Cessation Intervention and Service Ability Improvement

Smoking Cessation
University of Minnesota
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Varenicline and Smoking Cessation in Schizophrenia (VSCS)

Smoking Cessation | Schizophrenia

United States
Won Choi, PhD, MPH
National Cancer Institute (NCI)

Completed

Web-based Smoking Cessation Program for Tribal College Students

Smoking Cessation

United States
University of Pennsylvania
National Cancer Institute (NCI); Northwestern University

Recruiting

Optimizing Tobacco Use Treatment for PLWHA (HTO)

HIV/AIDS | Nicotine Dependence

United States
University of New Mexico
National Center for Complementary and Integrative Health (NCCIH)

Completed

Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy (Hyp-hOP)

Urinary Incontinence, Urge

United States
Yale University
National Institute on Drug Abuse (NIDA); US Department of Veterans Affairs

Completed

Efficacy of Varenicline in Methadone-Stabilized Cocaine Users

Nicotine Dependence | Cocaine Dependence

United States
Claudio Mendes Pannuti

Completed

Effect of Smoking Cessation on Clinical and Microbiological Outcomes of the Non-surgical Periodontal Therapy (EsCAPE2)

Periodontitis
University of Minnesota
National Institute on Drug Abuse (NIDA); Pfizer

Completed

Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence (ChanBan)

Nicotine Dependence | Nicotine Withdrawal

United States
GlaxoSmithKline

Completed

Bupropion & Cardio Birth Defect (Slone)

Depressive Disorder
Columbia University
University of Pennsylvania; Washington University School of Medicine; National... and other collaborators

Completed

Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)

Depression | Acute Coronary Syndrome

United States

Search clinical trials for: Varenicline Tartrate or bupropion

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations